Imunon, Inc. (IMNN) stock
IMNNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.58−0.03 (-5.26%)
Close on Nov 18, 2026Market cap $3.25MP/E –Yield –
Imunon operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Imunon's operating income for the twelve months ending Mar 31, 2026 was -$14.81M. For fiscal 2025 it was -$14.65M. The highest annual figure on record is -$14.65M in fiscal 2025.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$14.65M | – |
| FY2024 | Dec 31, 2024 | -$19.13M | – |
| FY2023 | Dec 31, 2023 | -$21.03M | – |
| FY2022 | Dec 31, 2022 | -$24.92M | – |
| FY2021 | Dec 31, 2021 | -$21.01M | – |
| FY2020 | Dec 31, 2020 | -$18.49M | – |
| FY2019 | Dec 31, 2019 | -$20.57M | – |
| FY2018 | Dec 31, 2018 | -$21.07M | – |
| FY2017 | Dec 31, 2017 | -$18.47M | – |
| FY2016 | Dec 31, 2016 | -$20.65M | – |
| FY2015 | Dec 31, 2015 | -$20.85M | – |
| FY2014 | Dec 31, 2014 | -$24.72M | – |
| FY2013 | Dec 31, 2013 | -$15.41M | – |
| FY2012 | Dec 31, 2012 | -$22.14M | – |
| FY2011 | Dec 31, 2011 | -$23.02M | – |
| FY2010 | Dec 31, 2010 | -$19.64M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2026 | Mar 31, 2026 | -$4.31M | – |
| Q4 FY2025 | Dec 31, 2025 | -$4.26M | – |
| Q3 FY2025 | Sep 30, 2025 | -$3.48M | – |
| Q2 FY2025 | Jun 30, 2025 | -$2.77M | – |
| Q1 FY2025 | Mar 31, 2025 | -$4.15M | – |
| Q4 FY2024 | Dec 31, 2024 | -$4.15M | – |
| Q3 FY2024 | Sep 30, 2024 | -$4.96M | – |
| Q2 FY2024 | Jun 30, 2024 | -$5.01M | – |
| Q1 FY2024 | Mar 31, 2024 | -$5.01M | – |
| Q4 FY2023 | Dec 31, 2023 | -$5.97M | – |
| Q3 FY2023 | Sep 30, 2023 | -$3.90M | – |
| Q4 FY2022 | Dec 31, 2022 | -$6.93M | – |
| Q3 FY2022 | Sep 30, 2022 | -$6.17M | – |
| Q2 FY2022 | Jun 30, 2022 | -$5.98M | – |
| Q1 FY2022 | Mar 31, 2022 | -$5.84M | – |
| Q4 FY2021 | Dec 31, 2021 | -$5.49M | – |
| Q3 FY2021 | Sep 30, 2021 | -$5.06M | – |
| Q2 FY2021 | Jun 30, 2021 | -$5.07M | – |
| Q1 FY2021 | Mar 31, 2021 | -$5.38M | – |
| Q4 FY2020 | Dec 31, 2020 | -$4.79M | – |
| Q3 FY2020 | Sep 30, 2020 | -$4.16M | – |
| Q2 FY2020 | Jun 30, 2020 | -$4.77M | – |
| Q1 FY2020 | Mar 31, 2020 | -$4.77M | – |
| Q4 FY2019 | Dec 31, 2019 | -$4.75M | – |
| Q3 FY2019 | Sep 30, 2019 | -$5.39M | – |
| Q2 FY2019 | Jun 30, 2019 | -$5.57M | – |
| Q1 FY2019 | Mar 31, 2019 | -$4.86M | – |
| Q4 FY2018 | Dec 31, 2018 | -$4.75M | – |
| Q3 FY2018 | Sep 30, 2018 | -$4.02M | – |
| Q2 FY2018 | Jun 30, 2018 | -$8.01M | – |
| Q1 FY2018 | Mar 31, 2018 | -$4.28M | – |
| Q4 FY2017 | Dec 31, 2017 | -$4.68M | – |
| Q3 FY2017 | Sep 30, 2017 | -$4.40M | – |
| Q2 FY2017 | Jun 30, 2017 | -$4.40M | – |
| Q1 FY2017 | Mar 31, 2017 | -$4.82M | – |
| Q4 FY2016 | Dec 31, 2016 | -$5.13M | – |
| Q3 FY2016 | Sep 30, 2016 | -$5.60M | – |
| Q2 FY2016 | Jun 30, 2016 | -$4.74M | – |
| Q1 FY2016 | Mar 31, 2016 | -$5.18M | – |
See a number that looks wrong?